1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Sjogren's syndrome Global Clinical Trials Review, H1, 2015

Sjogren's syndrome Global Clinical Trials Review, H1, 2015

Summary

GlobalData's clinical trial report, “Sjogren's syndrome Global Clinical Trials Review, H1, 2015" provides an overview of Sjogren’s syndrome clinical trials scenario. This report provides top line data relating to the clinical trials on Sjogren’s syndrome. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Sjogren's syndrome Global Clinical Trials Review, H1, 2015
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Sjogren's Syndrome 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Sjogren's Syndrome to Immunology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Sjogren's Syndrome to Immunology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Sjogren's Syndrome 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Sjogren's Syndrome Therapeutics Clinical Trials 30
Prominent Drugs 31
Latest Clinical Trials News on Sjogren's Syndrome 32
Mar 24, 2015: Aldeyra Therapeutics Announces First Patient Enrolled in Sjogren-Larsson Syndrome Phase II Clinical Trial 32
Mar 19, 2015: Kineta's ShK-186 Shows Encouraging Early Results as Potential Therapy for Autoimmune Eye Diseases 32
Mar 17, 2015: Aldeyra Therapeutics Opens Enrollment in Sjogren-Larsson Syndrome Clinical Trial and Finalizes Noninfectious Anterior Uveitis Clinical Trial Protocol 32
Mar 02, 2015: Aldeyra Therapeutics Provides Update on NS2 Clinical Program 33
Clinical Trial Profiles 34
Clinical Trial Overview of Top Companies 34
Novartis AG 34
Clinical Trial Overview of Novartis AG 34
F. Hoffmann-La Roche Ltd. 35
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 35
Volution Immuno Pharmaceuticals (VIP) SA 36
Clinical Trial Overview of Volution Immuno Pharmaceuticals (VIP) SA 36
Takeda Pharmaceutical Company Limited 37
Clinical Trial Overview of Takeda Pharmaceutical Company Limited 37
Parion Sciences, Inc. 38
Clinical Trial Overview of Parion Sciences, Inc. 38
Bristol-Myers Squibb Company 39
Clinical Trial Overview of Bristol-Myers Squibb Company 39
AstraZeneca PLC 40
Clinical Trial Overview of AstraZeneca PLC 40
Amgen Inc. 41
Clinical Trial Overview of Amgen Inc. 41
Akorn, Inc. 42
Clinical Trial Overview of Akorn, Inc. 42
Actavis plc 43
Clinical Trial Overview of Actavis plc 43
Clinical Trial Overview of Top Institutes / Government 44
National Institute of Dental and Craniofacial Research 44
Clinical Trial Overview of National Institute of Dental and Craniofacial Research 44
University Medical Center Groningen 45
Clinical Trial Overview of University Medical Center Groningen 45
Assistance Publique - Hopitaux de Paris 46
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 46
Chiba University 47
Clinical Trial Overview of Chiba University 47
Kanazawa Medical University 48
Clinical Trial Overview of Kanazawa Medical University 48
The National Institute of Allergy and Infectious Diseases 49
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 49
University of Sao Paulo 50
Clinical Trial Overview of University of Sao Paulo 50
Centre Hospitalier Regional Universitaire de Montpellier 51
Clinical Trial Overview of Centre Hospitalier Regional Universitaire de Montpellier 51
Centre Hospitalier Universitaire de Bordeaux 52
Clinical Trial Overview of Centre Hospitalier Universitaire de Bordeaux 52
Chang Gung Memorial Foundation 53
Clinical Trial Overview of Chang Gung Memorial Foundation 53
Five Key Clinical Profiles 54
Appendix 76
Abbreviations 76
Definitions 76
Research Methodology 77
Secondary Research 77
About GlobalData 78
Contact Us 78
Disclaimer 78
Source 78

List of Tables
Sjogren's Syndrome Therapeutics, Global, Clinical Trials by Region, 2015* 7
Sjogren's Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Sjogren's Syndrome Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Sjogren's Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Sjogren's Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Sjogren's Syndrome Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Sjogren's Syndrome Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Sjogren's Syndrome Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14
Proportion of Sjogren's Syndrome to Immunology Clinical Trials, G7 Countries (%), 2015* 15
Sjogren's Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Sjogren's Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Sjogren's Syndrome to Immunology Clinical Trials, E7 Countries (%), 2015* 18
Sjogren's Syndrome Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Sjogren's Syndrome Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Sjogren's Syndrome Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Sjogren's Syndrome Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Sjogren's Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Sjogren's Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Sjogren's Syndrome Therapeutics, Global, Withdrawn Clinical Trials, 2015* 25
Sjogren's Syndrome Therapeutics, Global, Terminated Clinical Trials, 2015* 26
Sjogren's Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 27
Sjogren's Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 28
Sjogren's Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 29
Sjogren's Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 30
Sjogren's Syndrome Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 31
Sjogren's Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 34
Sjogren's Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015* 35
Sjogren's Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Volution Immuno Pharmaceuticals (VIP) SA, 2015* 36
Sjogren's Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2015* 37
Sjogren's Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Parion Sciences, Inc., 2015* 38
Sjogren's Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2015* 39
Sjogren's Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2015* 40
Sjogren's Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2015* 41
Sjogren's Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Akorn, Inc., 2015* 42
Sjogren's Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Actavis plc, 2015* 43
Sjogren's Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Dental and Craniofacial Research, 2015* 44
Sjogren's Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by University Medical Center Groningen, 2015* 45
Sjogren's Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2015* 46
Sjogren's Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Chiba University, 2015* 47
Sjogren's Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Kanazawa Medical University, 2015* 48
Sjogren's Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2015* 49
Sjogren's Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Sao Paulo, 2015* 50
Sjogren's Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Hospitalier Regional Universitaire de Montpellier, 2015* 51
Sjogren's Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Hospitalier Universitaire de Bordeaux, 2015* 52
Sjogren's Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Chang Gung Memorial Foundation, 2015* 53

List of Figures
Sjogren's Syndrome Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Sjogren's Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Sjogren's Syndrome Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Sjogren's Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Sjogren's Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Sjogren's Syndrome Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Sjogren's Syndrome Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015* 14
Proportion of Sjogren's Syndrome to Immunology Clinical Trials, G7 Countries (%), 2015* 15
Sjogren's Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Sjogren's Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Sjogren's Syndrome to Immunology Clinical Trials, E7 Countries (%), 2015* 18
Sjogren's Syndrome Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Sjogren's Syndrome Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Sjogren's Syndrome Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Sjogren's Syndrome Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Sjogren's Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Sjogren's Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Sjogren's Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 27
Sjogren's Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 28
Sjogren's Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 29
Sjogren's Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 30
Sjogren's Syndrome Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 31
GlobalData Methodology 77

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.